Status:
COMPLETED
18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Breast Cancer
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The primary objective of the trial is to test the new radio tracer 18F-ASIS for PET imaging of tissue factor (TF) expression. The tracer has the potential of identifying tumors with high levels of TF ...
Detailed Description
The primary objective of the trial is to test the new radio tracer 18F-ASIS for PET imaging of tissue factor (TF) expression. The tracer has the potential of identifying tumors with high levels of TF ...
Eligibility Criteria
Inclusion
- Diagnosed with breast, lung, pancreatic, cervix or ovarian cancer
- Capable of understanding the patient information in Danish and giving full informed consent
Exclusion
- Pregnancy
- Breast-feeding
- Weight above 140 kg
- History of allergic reaction attributable to compounds of similar chemical or biologic composition to 18F-ASIS
Key Trial Info
Start Date :
January 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03790423
Start Date
January 3 2019
End Date
November 18 2019
Last Update
November 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100